Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vered Stearns

Showing results (31-40 of 273) with videos related to

Pageof 28
Sort By:
Annual Review of Medicine|January 14, 2011
Pharmacogenetics of endocrine therapy for breast cancerMichaela J Higgins, Vered Stearns
Journal of the National Cancer Institute|April 8, 2004
Déjà vu for breast cancer two?Vered Stearns, Nancy E Davidson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Cooling off hot flashesVered Stearns, Daniel F Hayes
Oncotarget|April 2, 2021
Innovating and expanding weight loss strategies for breast cancer survivorsJennifer Y Sheng, Vered Stearns
Expert Reviews in Molecular Medicine|November 21, 2008
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?Vered Stearns, James M Rae
JAMA Oncology|July 17, 2015
Gene Mutation Profiling of Breast Cancers for Clinical Decision Making: Drivers and Passengers in the Cart Before the HorseVered Stearns, Ben Ho Park
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Reply to K.I. PritchardN Lynn Henry, Vered Stearns
Breast Cancer Research and Treatment|October 14, 2010
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapyN Lynn Henry, Vered Stearns
Current Oncology Reports|April 29, 2010
CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevanceMichaela J Higgins, Vered Stearns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Treatment-emergent effects may predict benefit from endocrine therapyN Lynn Henry, Vered Stearns
Pageof 28

Showing results (31-40 of 273) with videos related to

Sort By:
Pageof 28
Annual Review of Medicine|January 14, 2011
Pharmacogenetics of endocrine therapy for breast cancerMichaela J Higgins, Vered Stearns
Journal of the National Cancer Institute|April 8, 2004
Déjà vu for breast cancer two?Vered Stearns, Nancy E Davidson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Cooling off hot flashesVered Stearns, Daniel F Hayes
Oncotarget|April 2, 2021
Innovating and expanding weight loss strategies for breast cancer survivorsJennifer Y Sheng, Vered Stearns
Expert Reviews in Molecular Medicine|November 21, 2008
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?Vered Stearns, James M Rae
JAMA Oncology|July 17, 2015
Gene Mutation Profiling of Breast Cancers for Clinical Decision Making: Drivers and Passengers in the Cart Before the HorseVered Stearns, Ben Ho Park
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2013
Reply to K.I. PritchardN Lynn Henry, Vered Stearns
Breast Cancer Research and Treatment|October 14, 2010
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapyN Lynn Henry, Vered Stearns
Current Oncology Reports|April 29, 2010
CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevanceMichaela J Higgins, Vered Stearns
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2013
Treatment-emergent effects may predict benefit from endocrine therapyN Lynn Henry, Vered Stearns
Pageof 28